A Case of Pulmonary Alveolar Proteinosis Improved with Inhaled Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

Bo-Hyoung KANG; Ho-Su LEE; Yumi LEE; So-Eun PARK; Woo-Sung KIM; Dong-Soon KIM; Jin-Woo SONG; Bo-Hyoung KANG; Ho-Su LEE; Yumi LEE; So-Eun PARK; Woo-Sung KIM; Dong-Soon KIM; Jin-Woo SONG.
Korean Journal of Medicine ; : 357-361, 2012.
Artículo en Ko | WPRIM | ID: wpr-741075

Documentos relacionados

  1. Pulmonary alveolar proteinosis - current and future therapeutical strategies.
  2. [Establishment and application of animal models of pulmonary alveolar proteinosis].
  3. Ten-year experience of whole lung lavage in pediatric Pulmonary Alveolar Proteinosis.
  4. Autoimmune Pulmonary Alveolar Proteinosis.
  5. [Consensus statement on inhaled recombinant human granulocyte-macrophage colony-stimulating factor for autoimmune pulmonary alveolar proteinosis (2022)].
  6. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
  7. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply.
  8. [Effectiveness and safety of inhaled granulocyte-macrophage colony-stimulating factor therapy in idiopathic pulmonary alveolar proteinosis].
  9. Granulocyte-Macrophage Colony-Stimulating Factor Inhalation Therapy for Severe Pulmonary Alveolar Proteinosis.
  10. Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner.